MIAMI--(BUSINESS WIRE)--New in vitro studies, led by renowned authority on respiratory diseases, conclude Xlear nasal spray is “an effective...and replicable means to deactivate SARS-CoV-2...to an ...
Nathan Jones, CEO of Xlear, said that he feels that his company is emerging from the COVID-19 pandemic in better shape and is prepared to help retailers in the post-COVID era. He talked with Drug ...
Recent Study on Computationally-Guided Intranasal Spray Protocol to Augment Therapeutic Penetration With Implications Shown for Effective Treatments for COVID-19, Rhinitis, and Sinusitis Nasal ...
AMERICAN FORK, Utah--(BUSINESS WIRE)--Today Xlear announced a new partnership with Dr. Ferrer BioPharma (DFBP), which will make Xlear nasal spray the first nasal hygiene tool to deploy the GentleMist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results